NCT01810705 - GRASPA Treatment for Patients With Acute Myeloblastic Leukemia | Biotech Hunter

Enrollment

123

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

November 10, 2017

Study Completion Date

November 10, 2017

Conditions

Acute Myeloid Leukemia

Interventions

DRUG

GRASPA

Patients receiving Intervention (experimental group) will be treated with one injection of graspa per cycle of treatment, each cycle during 28 days, for a duration up to 24 cycles maximum

Trial Locations (21)

13000

Institut Paoli Calmettes, Marseille

25000

Hôpital JEAN MINJOZ, Besançon

29200

Hopital Morvan, Brest

30000

CHRU de Nîmes, Nîmes

31500

Hopital De Purpan CHU Toulouse, Toulouse

33600

Hôpital Haut-Lévèque, Pessac

34295

Hôpital Saint Eloi, Montpellier

42270

Institut de Cancérologie de la Loire, Saint-priest-en-jarez

44200

Hôtel Dieu - CHU de NANTES, Nantes

49000

Chu D'Angers, Angers

54500

Hopital de Brabois, Vandœuvre-lès-Nancy

59800

Hôpital Claude-Huriez, Lille

63000

CHU Estaing, Clermont-Ferrand

66100

hopital de Perpignan, Perpignan

67000

Hopital de Hautepierre, Strasbourg

69008

Centre Léon Bérard, Lyon

69310

Centre hospitalier Lyon Sud, Pierre-Bénite

74000

Hopital Région d'Annecy, Pringy

76100

Centre Henri Becquerel, Rouen

80090

Groupe Hospitalier Sud, Amiens

06200

Hôpital l'Archet 1, Nice